trarily chosen oligonucleotide primers (RAPD) [6] . Use of this technique to type C. neoformans has demonstrated marked heterogeneity among strains [7] [8] [9] . However, in most cases, a single primer or a small number of primers was used, and experience with RAPD analysis of cryptococcal strains remains limited. We have shown previously that a modification of the RAPD technique using 20-to 22-mer primers in pairs produces stable DNA patterns that clearly distinguish between the 2 varieties of C. neoformans [10] .
Although most cryptococcal disease is caused by C. n. var. neoformans serotype A, there is evidence that strains vary in their pathogenicity [11] . Furthermore, infection occurs in both immunocompromised and immunocompetent hosts. There is in general a paucity of information relating strain variation in cryptococci to host factors; one analysis of C. neoformans serotype D isolates suggested an association between strain characteristics and individual risk factors for human immunodeficiency virus (Hl'V) infection [12] . We describe the analysis by RAPD of 60 clinical isolates of C. n. var. neoformans and relate the RAPD profile to the epidemiology of the infection and to underlying host disease.
Materials and Methods
Cryptococcalstrains. Clinical isolates of C. n. var. neoformans were obtained from Westmead Hospital, Women's and Children's Hospital, Princess Alexandra Hospital, and Fairfield Hospital. Two North American clinical isolates were a gift from S. Rosenthal (New York Medical Center, New York City). All isolates were identified and biotyped by standard techniques [2] . Serotyping was done using the Crypto Check agglutination test (latron Laboratories, Tokyo). For each isolate, a single colony was picked and subcultured twice on Sabouraud's dextrose agar. Cultures were maintained at 30°C in air for n h before DNA extraction.
DNA preparation. Cells were disrupted by boiling for 20 min in extraction buffer (0.2 M sodium hydroxide, 0.4% N-Iauroylsarcosine, 20 roM EDTA) in microcentrifuge tubes. Samples were then centrifuged for 5 min at 14,000 g. Supernatants were transferred to a clean microcentrifuge tube containing 0.5 vol of 7.5 M ammonium acetate, mixed, and centrifuged as before. The supernatant was transferred to a clean tube, and DNA was precipitated with 0.6 vol of isopropanol at room temperature. Centrifuged pellets were suspended in I mL of 10 roM TRIS with I roM EDTA, pH 8.0 (TE), and extracted twice with phenol-chloroform-isoamyl alcohol (25:24:1) [13] . DNA was precipitated using 1110 vol of 3 M sodium acetate, pH 5.2, and I vol of isopropanol. The centrifuged pellet was redissolved in 0.5 mL of 0.05 MTE [13] and 0.28 M sodium chloride, pH 6.0, precipitated with 0.1% cetyltrimethyl ammonium bromide, washed with 70% ethanol, and resuspended in 50 f.tL of TE. DNA concentrations were determined spectrophotometrically.
RAPD analysis. Three 20-to 22-mer primers were chosen arbitrarily from laboratory stocks; their designations and sequences are (5' to 3'): CNI (TACCCCCGCCCATATTCCAT), MYCI (GAGGAAGGTGGGGATGACGT), and 5S0R (ATGGGAA-TACGACGTGCTGTAG). They were used in three combinations: CNlIMYCI, MYC1I5S0R, and 5S0RlCNl. In addition, 3 12-mer primers: FPKI-01 (ACACGGACGTCA), FPKI-05 (ACTTGG-CGGCCT), and FPKI-07 (ACCCTGCTCATC) (Bresatec, Thebarton, Australia) were used in two combinations: FPKI-OllFPKI-05 and FPKI-05FPKlI-07. RAPD analysis was thus done with five primer pairs. PCR was done in a thermal cycler (PTC-IOO; MJ Research, Bresatec) using 25-f.tL reaction volumes, each containing~lOng of genomic DNA, 10 pmol of each of the two primers, 6 roM MgCIz, 200 f.tM each dNTP, and 0.75 U of Taq DNA polymerase (Promega, Sydney) under the recommended buffer conditions. Reactions were cycled 10 times at 93°C for I min, 35°C for I min, and noc for I min followed by 20 cycles at 93°C for 1 min, 55°C for I min, noc for 1 min, and noc for 5 min. Where the primer pair 5S0RlCNI was used, the annealing temperature was changed to 40°C for I min at low-stringency conditions.
Products of amplification were electrophoresed in a 7% polyacrylamide gel and visualized by silver staining (BioRad Laboratories, North Ryde, Australia). Band sizes were estimated from comigrating 100-bp DNA molecular size standards (Life Technologies GIBCO BRL, Five Dock, Australia).
DNA preparations made from 2 separate cultures of each isolate were run in parallel in RAPD analysis. RAPD assays of each DNA preparation were repeated at least once. Reproducibility of the method was confirmed by analyzing further DNA preparations from selected isolates on different occasions and by repeating experiments on stored DNA preparations over a 2-year period and in two different laboratories under identical test conditions. In all instances, identical profiles were obtained. Variations were sometimes observed in the intensities of amplicons from separate DNA preparations of the same organism despite standardization of DNA template concentrations. RAPD profiles were thus scored according to the number and reproducibility of bands independent of their intensity. A major profile was defined as a pattern that was reproducible and distinct from the others by at least four of the five primer combinations. Subtypes were defined by a consistent difference in profile associated with the use of one primer pair. Assignment of patterns to major and minor profiles was validated by an independent observer. Isolates that were not serotyped (or untypeable) were assigned to a serotype on the basis oftheir RAPD profile. Statistical analysis was done using the X 2 test or Fisher's exact test.
Results
Sixty-three isolates of C. n. var. neoformans from 60 patients were studied. Concurrent isolates were available from two body sites (cerebrospinal fluid [CSF] and blood) in each of2 patients and from CSF obtained initially and 6 months later from 1 patient; in each instance the first isolate obtained was selected as the representative strain for the study. A total of 60 isolates was included in scoring the RAPD profiles.
Five major RAPD profiles were identified using the 20-to 22-mer primer combinations (figure lA, B). Amplification with the primer pair CN1/MYC1 (figure lA, table 1) showed that for serotype A isolates, 42 (n%) of 58 fell into profile I. Profile II comprised 13 (22%) and profile III comprised 3 (5%) isolates. Profiles IV and V consisted of 1 isolate each of serotype AD and D, respectively. The primer combination 5S0R/ CN1 revealed 5 subtypes within profile I (figure IB, C). Thirtyseven of the 42 (88%) isolates were classed as profile Ia. Profiles Ib, Ie, and Id comprised 1 isolate each, while 2 cryptococcal strains were assigned to profile Ie. The 12-mer primer pairs distinguished only 4 major profiles.
There was a good correlation between the RAPD profile and serotype of C. n. var. neoformans. Forty-one isolates were serotyped; 38 were serotype A, 1 was serotype D, I was serotype AD, and 1 was untypeable. The 19 isolates that were not serotyped and the strain that could not be serotyped had profiles typical of serotype A.
RAPD profile and host status. Two isolates were obtained from HIV-infected persons in New York City. Of 58 Australasian isolates, 28 were from patients with AIDS, 20 from immunocompetent hosts, and 10 from patients with immunosuppression due to malignancy, connective tissue disorder, or immunosuppressive therapy. The relationship between RAPD profile and underlying host conditions is shown in * Not all strains were serotyped; however, RAPD profiles indicate serotype A. (5), and North America (2) . RAPD profiles were independent of the geographic origin of isolates.
Our analysis of 60 clinical isolates of C. n. var. neoformans confirms previous observations that genetic polymorphisms are present in C. neoformans [5] [6] [7] [8] [9] 14] . We have also shown that RAPD analysis can discriminate effectively between strains of C. n. var. neoformans and that our method is suitable for largescale epidemiologic studies.
This study is the first to demonstrate a distinct molecular profile of C. n. var. neoformans serotype A in patients with AIDS and includes isolates from different continents. In contrast, molecular typing methods applied previously to C. n.
var. neoformans from AIDS patients have indicated substantial genetic diversity [7, 12, 14] . Dromer et al. [12] noted that selected DNA patterns may be associated with different risk factors for acquisition of HIV, though the number of patients in each risk group was small. The majority of HIV patients in our study acquired their infection via homosexual activity. The explanation of a common molecular profile in cryptococcal isolates from HIV-infected patients is uncertain. Possibilities include a point source of infection, person-to-person spread, and the selection of a particular molecular type of C.
neoformans in the presence of immunodeficiency. The first two possibilities cannot readily explain the occurrence of the same molecular type from two continents and many sites across Australasia, although demographic data and travel patterns of the patients are not available. Within the Australian isolates, we noted that RAPD profile Ia occurred frequently in patients RAPD profile and body site of recovery. Isolates were recovered from CSF (40), lung (8), blood (5), skin or soft tissue (4), and bone (1). Thirty-one (78%) of 40 CSF isolates were assigned to profile I, 5 to profile II, 2 to profile III, and 1 each to profiles IV and V. Six (75%) of8lung isolates were assigned to profile II (OR, 17.6; 95% CI, 2.4-162; P = .001); 5 of the 6 were recovered from immunocompetent patients, as were 77% of isolates assigned to this profile. After allowing for host status, there was no apparent link between RAPD profile and the clinical source of isolates. Of the remaining 10 isolates, 8
Ia Ib
Ie Id Ie II III IV V immunocompromised by conditions other than HIV as well as those with AIDS in the absence of common environmental exposure. Person-to-person spread of infection has been documented only once, during corneal transplantation from a patient with disseminated cryptococcosis [15] . There may be a predominant environmental strain in Australia; however, the broad spectrum ofRAPD patterns in immunocompetent patients from similar locations suggests this is unlikely. Analysis of environmental isolates is underway.
RAPD profiles in our study were predictive of serotype in C. n. var. neoformans, as has been observed with alternative methods of differentiating DNA patterns [5, 9] . However, Crampin et al. [7] reported that RAPD analysis of 12 isolates of C. neoformans yielded a unique pattern for each, without correlation with serotype. The discrepancy may be due to their use of a single short primer for DNA amplification. In our hands, the 20-to 22-mer primers produced reproducible and more informative profiles than did 12-mer primers, although the latter were useful in confirming major profiles. We chose to use coupled primers, as variable results were noted with the use of single primers. Others recommend the use of at least two primers together to detect a higher number of polymorphisms and to maximize reproducibility [16] .
Isolate pairs from the same person taken at different times or from different body sites at the same time produced identical profiles, suggesting that relapse of infection occurred with the same molecular type of C. neoformans and that, in disseminated infection, the population of cryptococci is homogenous. This confirms the findings of previous studies using alternative typing methods [4, 5, 17] . In contrast, one group used RAPD analysis and DNA restriction fragment length polymorphism (RFLP) analysis to demonstrate genetically distinct cryptococcal strains in 5 patients with AIDS [8] . These results were evident with only 1 of 3 primers used in the RAPD and were confirmed by 1 of 5 probes used in the RFLP analysis. Since the probes and primers were directed at microsatellite sequences in C. neoformans, the Southern blot hybridization results were not independent of the RAPD analyses. Though these results raise the possibility of coinfection with different cryptococcal strains and of reinfection with a unique strain, they require confirmation.
RAPD profile II predominated among the small numbers of isolates recovered from lung in our study; however, lung isolates were primarily obtained from immunocompetent patients. In this group, the majority of isolates were also assigned to profile II. Dromer et al. [12] , using two alternative molecular techniques, observed that serotype D isolates obtained from the lungs of HIV-infected patients in France were associated with a predominant identifying pattern. Analysis of more cryptococcal isolates from different clinical sources is required to determine if strains differ in their tropism for a given organ or if variation is dependent on the host's ability to control infection. In our study, RAPD profiles of isolates recovered from immunocompetent patients can, in most circumstances, be distinguished from those obtained from patients with an immunodeficiency. lt is possible, but untested, that cell-or complementmediated immune mechanisms or cofactors associated with HIV infection or immunosuppressive therapy contribute to selection of a predominant cryptococcal genotype and that the amplicons obtained by RAPD represent sequences linked to cryptococcal virulence. RAPD analysis of serotype A isolates obtained from additional AIDS patients from different countries is required to confirm the epidemiologic association.
